243 related articles for article (PubMed ID: 34545201)
1. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
[TBL] [Abstract][Full Text] [Related]
2. Evolution of healthcare costs for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller E; Matlaga BR; McVary K;
Int Urol Nephrol; 2022 Nov; 54(11):2797-2803. PubMed ID: 35906501
[TBL] [Abstract][Full Text] [Related]
3. National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men.
Doolin J; Reese ZA; Mukamal KJ
World J Urol; 2021 Mar; 39(3):855-860. PubMed ID: 32448971
[TBL] [Abstract][Full Text] [Related]
4. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
[TBL] [Abstract][Full Text] [Related]
5. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
6. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
[TBL] [Abstract][Full Text] [Related]
7. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
[TBL] [Abstract][Full Text] [Related]
8. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.
Egan KB
Urol Clin North Am; 2016 Aug; 43(3):289-97. PubMed ID: 27476122
[TBL] [Abstract][Full Text] [Related]
9. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
[TBL] [Abstract][Full Text] [Related]
10. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
Park JS; Koo KC; Kim HK; Chung BH; Lee KS
Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
[TBL] [Abstract][Full Text] [Related]
11. Smoking and lower urinary tract symptoms in Reduction by Dutasteride of Prostate Cancer Events Trial.
Kramer JJ; Gu L; Moreira D; Andriole G; Freedland SJ; Csizmadi I
Prostate; 2023 Jul; 83(10):990-997. PubMed ID: 37070723
[TBL] [Abstract][Full Text] [Related]
12. Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.
María Molero J; Miñana B; Palacios-Moreno JM; Téllez Martínez-Fornes M; Lorite Mingot D; Agra Rolán A; Carreño Á; Cuervo Pinto R
Int J Clin Pract; 2020 Nov; 74(11):e13602. PubMed ID: 32609933
[TBL] [Abstract][Full Text] [Related]
13. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
Egan KB; Suh M; Rosen RC; Burnett AL; Ni X; Wong DG; McVary KT
Int J Clin Pract; 2015 Nov; 69(11):1316-25. PubMed ID: 26215544
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.
Verhamme KM; Dieleman JP; Bleumink GS; van der Lei J; Sturkenboom MC; Artibani W; Begaud B; Berges R; Borkowski A; Chappel CR; Costello A; Dobronski P; Farmer RD; Jiménez Cruz F; Jonas U; MacRae K; Pientka L; Rutten FF; van Schayck CP; Speakman MJ; Sturkenboom MC; Tiellac P; Tubaro A; Vallencien G; Vela Navarrete R;
Eur Urol; 2002 Oct; 42(4):323-8. PubMed ID: 12361895
[TBL] [Abstract][Full Text] [Related]
15. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.
Haghpanah A; Masjedi F; Salehipour M; Hosseinpour A; Roozbeh J; Dehghani A
Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):27-38. PubMed ID: 34007019
[TBL] [Abstract][Full Text] [Related]
16. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.
Patel DN; Feng T; Simon RM; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Roehrborn C; Andriole GL; Freedland SJ
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):238-244. PubMed ID: 29795141
[TBL] [Abstract][Full Text] [Related]
17. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.
Lerner LB; McVary KT; Barry MJ; Bixler BR; Dahm P; Das AK; Gandhi MC; Kaplan SA; Kohler TS; Martin L; Parsons JK; Roehrborn CG; Stoffel JT; Welliver C; Wilt TJ
J Urol; 2021 Oct; 206(4):806-817. PubMed ID: 34384237
[TBL] [Abstract][Full Text] [Related]
18. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
19. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
20. Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia.
Lee D; Koo KC; Yoo JW; Lee KS
Low Urin Tract Symptoms; 2022 Jan; 14(1):35-40. PubMed ID: 34323012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
